"Designing Growth Strategies is in our DNA"

Peptide Mapping Market Size, Share & Industry Analysis, By Product (Consumables, Instruments, Software, and Services & Workflow Solutions), By Application (Biologics Characterization, QC & Release Testing, Stability Testing, and Others), By Technology (LC-MS/MS Peptide Mapping, LC-MS Peptide Mapping, LC-UV / HPLC-UV Peptide Mapping, and Others), By Type of Peptide (Monoclonal Antibody-derived Peptides, and Others), By End User (Pharmaceutical & Biotechnology Companies, CROs/CDMOs & Analytical Testing Labs, Academic & Research Institutes, and Others), and Regional Forecast, 2026-2034

Last Updated: June 26, 2026 | Format: PDF | Report ID: FBI117773

 


To get information on various segments, share your queries with us

ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year  2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 9.05% from 2026 to 2034
Unit Value (USD Million)
Segmentation By Product, Application, Technology, Type of Peptide, End User, and Region
By Product 
  • Consumables
  • Instruments
  • Reagents & Enzymes
  • Software, Services & Workflow Solutions
By Application
  • Biologics Characterization
  • QC & Release Testing
  • Biosimilar Comparability
  • Stability Testing
  • Process Development
  • Peptide Drug Analysis
  • Others
By  Technology
  • LC-MS/MS Peptide Mapping
  • LC-MS Peptide Mapping
  • LC-UV / HPLC-UV Peptide Mapping
  • Others
By Type of Peptide
  • Monoclonal Antibody-derived Peptides
  • Recombinant Protein-derived Peptides
  • Synthetic Therapeutic Peptides
  • Biosimilar Product-derived Peptides
  • ADC-derived Peptides
  • Others
By  End User
  • Pharmaceutical & Biotechnology Companies
  • CROs/CDMOs & Analytical Testing Labs
  • Academic & Research Institutes
  • Others
By Region 
  • North America (By Product, Application, Technology, Type of Peptide, End User, and Country)
    • U.S. 
    • Canada
  • Europe (By Product, Application, Technology, Type of Peptide, End User, and Country/Sub-region)
    • Germany 
    • U.K.
    • France 
    • Spain 
    • Italy 
    • Scandinavia 
    • Rest of Europe
  • Asia Pacific (By Product, Application, Technology, Type of Peptide, End User, and Country/Sub-region)
    • China 
    • Japan 
    • India 
    • Australia 
    • Southeast Asia 
    • Rest of Asia Pacific 
  • Latin America (By Product, Application, Technology, Type of Peptide, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Application, Technology, Type of Peptide, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

 

  • 2021-2034
  • 2025
  • 2021-2024
  • 198
Download Free Sample

    man icon
    Mail icon

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann